Asep Medical Holdings Inc. Announces Leadership Transition by asepadmin | Feb 21, 2026 | Uncategorized
Asep Medical Holdings Amends and Refiles its Management’s Discussion & Analysis for its Year Ended December 31, 2024 by asepadmin | Dec 11, 2025 | Uncategorized
Asep Medical Holdings Licenses its Anti-Biofilm Technology to Bondent Group for Oral Rinse Development and Commercialization in China by asepadmin | Nov 10, 2025 | Uncategorized
Asep Medical Raises 5 Million RMB Through the Sale of a 10% Stake in Chinese Joint Venture by asepadmin | Sep 12, 2025 | Uncategorized
Asep Medical Validates its SepsetER Diagnostic Test in Patients in Leading Scientific Journal, Nature Communications. by asepadmin | May 27, 2025 | Uncategorized
